Nieves Gisbert-Garcia

Barcelona, CT 08003, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma.

Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma.

Journal: Cancers
Published: January 26, 2026

Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.

Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.

Journal: Cancers
Published: December 09, 2023

Leukemic Involvement Is a Common Feature in Waldenström Macroglobulinemia at Diagnosis.

Leukemic Involvement Is a Common Feature in Waldenström Macroglobulinemia at Diagnosis.

Journal: Cancers
Published: July 21, 2023

Sex-associated differences in genomic profile of chronic myelomonocytic leukemia involving differential representation of SRSF2 gene mutation.

Sex-associated differences in genomic profile of chronic myelomonocytic leukemia involving differential representation of SRSF2 gene mutation.

Journal: International journal of laboratory hematology
Published: March 21, 2023

MultiCOVID: a multi modal deep learning approach for COVID-19 diagnosis.

MultiCOVID: a multi modal deep learning approach for COVID-19 diagnosis.

Journal: Scientific reports
Published: February 10, 2023

Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia.

Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia.

Journal: Leukemia
Published: July 07, 2022

First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma.

First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma.

Journal: Blood advances
Published: June 22, 2022

Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.

Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.

Journal: Blood advances
Published: February 17, 2022

Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA.

Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA.

Journal: Blood advances
Published: November 12, 2021

Circulating cell-free DNA improves the molecular characterisation of Ph-negative myeloproliferative neoplasms.

Circulating cell-free DNA improves the molecular characterisation of Ph-negative myeloproliferative neoplasms.

Journal: British journal of haematology
Published: June 18, 2020

Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features.

Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features.

Journal: Blood advances
Published: May 01, 2020

Analysis of saliva samples and cluster of differentiation 3 (CD3)+ lymphocytes as a source of germline DNA in myeloproliferative neoplasms.

Analysis of saliva samples and cluster of differentiation 3 (CD3)+ lymphocytes as a source of germline DNA in myeloproliferative neoplasms.

Journal: British journal of haematology
Published: December 12, 2019
Showing 1-12 of 12

Last Updated: 09/26/2026